Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arcturus Therapeutics Holdings Inc (NQ: ARCT )

39.45 USD +2.46 (+6.65%)
Official Closing Price Updated: 7:50 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arcturus Therapeutics Holdings Inc

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences 
From Business Wire News Releases
Which Late-to-the-Party COVID Vaccine Stocks Could Still Be Winners?
There's at least one biotech that appears to be a potential contender. 
Tags CVAC MRNA BAYR/Y
From Motley Fool
Stock Upgrades: Alcobra Shows Rising Relative Strength
A Relative Strength Rating upgrade for Alcobra shows improving technical performance. 
From Investor's Business Daily
RSI Alert: Arcturus Therapeutics Holdings (ARCT) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Arcturus Therapeutics: Q4 Earnings Insights
Shares of Arcturus Therapeutics (NASDAQ:ARCT) fellin after-market trading after the company reported Q4 results. Quarterly ... 
Tags ARCT Market News Earnings
From Benzinga
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates 
From Business Wire News Releases
Earnings Scheduled For March 1, 2021
Companies Reporting Before The Bell • Athenex (NASDAQ:ATNX) is likely to report quarterly loss at $0.44 per share on ... 
Tags SPNE VIE ASTE
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags BOLT LHDX Biotech
From Benzinga
Arcturus Therapeutics Holdings Breaks Below 200-Day Moving Average - Notable for ARCT
In trading on Tuesday, shares of Arcturus Therapeutics Holdings Inc (ARCT) crossed below their 200 day moving average of $57.34, changing hands as low as $50.01 per share. Arcturus Therapeutics... 
Tags Stocks
From Market News Video
Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals
Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals 
From Business Wire News Releases
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021 
From Business Wire News Releases
TransCode Therapeutics Announces Key Appointments
TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its... 
From Business Wire News Releases
Arcturus Therapeutics to Present at Upcoming Investor Conferences
Arcturus Therapeutics to Present at Upcoming Investor Conferences 
From Business Wire News Releases
Is It Too Late to Buy These 3 COVID Vaccine Latecomer Stocks?
Probably not, if you're investing for the long term. 
Tags INO Market News VXRT
From Motley Fool
3 Biotech Stocks To Watch This Week
Tags Market News
From StockMarket.com
Is Arcturus Therapeutics a Buy?
Only if its COVID-19 vaccine proves to be at least as effective than those developed by its rivals. 
Tags PFE MRNA ARCT
From Motley Fool
3 Top Biotech Stocks To Put On Your January 2021 Watchlist
Tags Market News
From StockMarket.com
Should you invest in Tesla, Arcturus Therapeutics, Boeing, AT&T, or Uber Technologies?
InvestorsObserver issues critical PriceWatch Alerts for TSLA, ARCT, BA, T, and UBER. 
From PR Newswire
Stocks Off To Strong Start To 2021
The average stock in the Russell 3,000 is already up 5.24% year-to-date after just four trading days. And to think, major indices were down ~1% on the first trading day of the year this past Monday. 
Tags Stocks / Equities
From Blogs - TalkMarkets
95 Biggest Movers From Yesterday
Gainers Future FinTech Group Inc. (NASDAQ: FTFT) shares climbed 242.3% to close at $5.75 on Thursday as the company said China ... 
Tags MARA SCPS ISNS
From Benzinga
Noteworthy Thursday Option Activity: BCPC, CACC, ARCT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Balchem Corp. (BCPC), where a total of 1,133 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Why Arcturus Therapeutics Stock Skyrocketed Today
One Wall Street analyst is very bullish about the biotech's prospects. 
Tags ARCT Market News
From Motley Fool
Why Teladoc Health, Arcturus And Meridian Are Moving Today
Arcturus Therapeutics (NASDAQ: ARCT) shares are trading higher on Thursday after Wells Fargo initiated coverage on the stock with an ... 
Tags Small Cap Movers Market News
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Oxford Immunotec Global (NASDAQ:OXFD) stock increased by 27.21% to $22.0 during Thursday's regular session. ... 
Tags Markets ARCT VRAY
From Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Gainers Future FinTech Group Inc. (NASDAQ: FTFT) shares jumped 187% to $4.82 as the company said China Copyright Protection Center ... 
Tags NRBO FTFT SPCB
From Benzinga
Benzinga's Top Upgrades, Downgrades For January 7, 2021
Upgrades According to Citigroup, the prior rating for Sealed Air Corp (NYSE:SEE) was changed from Neutral to Buy. For ... 
Tags LMT MOS CNA
From Benzinga
Did You Miss Out on the Chance for Big Gains from Arcturus Stock?
The biotech's shares jumped by 299% last year, propelled by optimism about its COVID-19 vaccine candidate. 
Tags PFE MRNA ARCT
From Motley Fool
Arcturus Therapeutics to Present at Upcoming Investor Conference
Arcturus Therapeutics to Present at Upcoming Investor Conference 
From Business Wire News Releases
Why Is Everyone Talking About Arcturus Therapeutics Stock?
This clinical-stage biotech has been a wild ride for investors, and the shifting outlook for its COVID-19 vaccine candidate is the reason why. 
Tags PFE MRNA ARCT
From Motley Fool
Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United States
Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United States 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.